Company Overview
Snapshot
Founded in August 2023, Watershed AC operates with 1–10 employees. The company has secured one funding round and received a grant from the Israel Innovation Authority in May 2024.
Business overview
Watershed AC is an Israel-based biotechnology company focused on sustainable aquaculture. The company develops advanced gene-editing technologies, such as CRISPR, to enhance crustacean traits including growth rate, disease resistance, and environmental adaptation. It operates within the Agriculture & Food Technologies sector, specifically targeting Ag Tech and Genetics & Input categories.
Strategic signal
In October 2024, Watershed AC, in collaboration with Evogene and Ben-Gurion University, received approval for a second-year grant from the Israel Innovation Authority. This continuation of their partnership aims to scale up CRISPR technology for industrial use in crustaceans, addressing limitations in gene editing for non-model organisms. This signals strong validation of their gene-editing approach and potential for significant advancements in sustainable aquaculture, particularly for the growing global shrimp and crayfish markets.
Log in to access full profile ›Company Intelligence Q&A
- What is Watershed AC's primary focus?
- Watershed AC focuses on developing advanced gene-editing technologies, including CRISPR, to improve crustacean traits such as growth rate, disease resistance, and environmental adaptation for sustainable aquaculture.
- When was Watershed AC founded?
- Watershed AC was founded in August 2023.
- Has Watershed AC received any grants?
- Yes, in May 2024, Watershed AC received a grant from the Israel Innovation Authority.
- What significant collaboration is Watershed AC involved in?
- In October 2024, Watershed AC, Evogene, and Ben-Gurion University received approval for a second-year grant from the Israel Innovation Authority to continue their collaboration on developing CRISPR technology for crustaceans.
- What is the goal of the collaboration with Evogene and Ben-Gurion University?
- The collaboration aims to address limitations in gene editing for non-model organisms, focusing on improving traits like growth rate and disease resistance in crustaceans, with plans to scale the technology for industrial use.